A new drug is being trialed at the Oxford Experimental Cancer Medicine Centre,
which doctors hope will help in the fight against certain genetic cancers,
announces Cancer Research, who are funding the trial. The Centre hopes to help
women with faults in the BRAC1 and BRAC2 genes, which increase the chances
of developing breast cancer.

The drug, known as 6MP, has shown very encouraging results in laboratory
tests, and now moves onto the clinical trial phase.